A Study of PRA052 in Healthy Volunteers
Clinical trial NCT05603182 · COMPLETED
Trial details
- NCT number
- NCT05603182
- Sponsor
- Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-07
- Primary completion
- 2024-02-21
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.